methacetin has been researched along with Non-alcoholic Fatty Liver Disease in 5 studies
methacetin: RN given refers to parent cpd
methacetin : A member of the class of acetamides that is paracetamol in which the hydrogen of phenolic hydroxy group has been replaced by a methyl group.
Non-alcoholic Fatty Liver Disease: Fatty liver finding without excessive ALCOHOL CONSUMPTION.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in many parts of the world." | 5.39 | The role of ¹³C-methacetin breath test for the non-invasive evaluation of nonalcoholic fatty liver disease. ( Braticevici, B; Fierbinteanu-Braticevici, C; Panaitescu, E; Plesca, DA; Tribus, L, 2013) |
| "Overweight, obesity and liver fat accumulation manifest with deranged portal extraction efficiency of methacetin into the steatotic hepatocyte." | 4.31 | Liver fat accumulation more than fibrosis causes early liver dynamic dysfunction in patients with non-alcoholic fatty liver disease. ( Andrade, R; Bonfrate, L; Di Ciaula, A; Macedo, MP; Pina, A; Portincasa, P; Raposo, JF; Ribeiro, R; Shanmugam, H, 2023) |
| "Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in many parts of the world." | 1.39 | The role of ¹³C-methacetin breath test for the non-invasive evaluation of nonalcoholic fatty liver disease. ( Braticevici, B; Fierbinteanu-Braticevici, C; Panaitescu, E; Plesca, DA; Tribus, L, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 4 (80.00) | 2.80 |
| Authors | Studies |
|---|---|
| Di Ciaula, A | 3 |
| Shanmugam, H | 2 |
| Ribeiro, R | 1 |
| Pina, A | 1 |
| Andrade, R | 1 |
| Bonfrate, L | 3 |
| Raposo, JF | 1 |
| Macedo, MP | 1 |
| Portincasa, P | 3 |
| Weber, SN | 1 |
| Krawczyk, M | 1 |
| Sklyarova, HE | 1 |
| Carbone, F | 1 |
| Shanmugham, H | 1 |
| Molina-Molina, E | 1 |
| Ministrini, S | 1 |
| Montecucco, F | 1 |
| Fierbinteanu-Braticevici, C | 1 |
| Plesca, DA | 1 |
| Tribus, L | 1 |
| Panaitescu, E | 1 |
| Braticevici, B | 1 |
5 other studies available for methacetin and Non-alcoholic Fatty Liver Disease
| Article | Year |
|---|---|
Liver fat accumulation more than fibrosis causes early liver dynamic dysfunction in patients with non-alcoholic fatty liver disease.
Topics: Biomarkers; Diabetes Mellitus, Type 2; Humans; Liver; Liver Cirrhosis; Non-alcoholic Fatty Liver Dis | 2023 |
Effects of MBOAT7 polymorphism and steatosis on liver function assessed by methacetin breath test.
Topics: Acyltransferases; Humans; Liver; Liver Cirrhosis; Membrane Proteins; Non-alcoholic Fatty Liver Disea | 2023 |
13C-METHACETIN BREATHE TEST IN EARLY DIAGNOSTICS OF NON-ALCOHOLIC FATTY LIVER DISEASE.
Topics: Acetamides; Breath Tests; Carbon Isotopes; Female; Humans; Liver Cirrhosis; Male; Non-alcoholic Fatt | 2021 |
Adiponectin involved in portal flow hepatic extraction of 13C-methacetin in obesity and non-alcoholic fatty liver.
Topics: Acetamides; Adiponectin; Adult; Carbon Isotopes; Humans; Liver; Non-alcoholic Fatty Liver Disease; O | 2021 |
The role of ¹³C-methacetin breath test for the non-invasive evaluation of nonalcoholic fatty liver disease.
Topics: Acetamides; Adult; Analysis of Variance; Area Under Curve; Biomarkers; Biopsy; Breath Tests; Carbon | 2013 |